51,499 Shares in McKesson Corporation $MCK Acquired by Quadrature Capital Ltd

Quadrature Capital Ltd purchased a new position in McKesson Corporation (NYSE:MCK) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 51,499 shares of the company’s stock, valued at approximately $37,741,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Nuveen LLC bought a new stake in shares of McKesson during the first quarter valued at approximately $475,235,000. Wellington Management Group LLP increased its holdings in McKesson by 4,559.6% in the 1st quarter. Wellington Management Group LLP now owns 427,703 shares of the company’s stock valued at $287,840,000 after acquiring an additional 418,524 shares during the last quarter. Boston Partners increased its holdings in McKesson by 33.3% in the 1st quarter. Boston Partners now owns 1,461,785 shares of the company’s stock valued at $984,927,000 after acquiring an additional 365,484 shares during the last quarter. Voya Investment Management LLC lifted its stake in McKesson by 92.3% in the 1st quarter. Voya Investment Management LLC now owns 650,851 shares of the company’s stock worth $437,760,000 after purchasing an additional 312,473 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of McKesson by 68.0% during the 2nd quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock valued at $466,441,000 after purchasing an additional 257,670 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were sold at an average price of $861.63, for a total transaction of $283,476.27. Following the transaction, the chief accounting officer directly owned 328 shares in the company, valued at approximately $282,614.64. This represents a 50.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.08% of the company’s stock.

Wall Street Analyst Weigh In

MCK has been the topic of several research reports. Wells Fargo & Company lifted their target price on McKesson from $816.00 to $914.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Weiss Ratings reaffirmed a “buy (a-)” rating on shares of McKesson in a report on Tuesday. Cowen reissued a “buy” rating on shares of McKesson in a report on Wednesday, September 24th. Finally, JPMorgan Chase & Co. boosted their price target on shares of McKesson from $821.00 to $853.00 and gave the stock an “overweight” rating in a research report on Friday, September 26th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $887.69.

McKesson Stock Performance

Shares of McKesson stock opened at $884.76 on Friday. The stock has a market cap of $109.20 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51. The stock has a 50 day moving average price of $803.50 and a 200-day moving average price of $739.53. McKesson Corporation has a one year low of $558.13 and a one year high of $895.58.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.84 by $1.02. The company had revenue of $103.15 billion during the quarter, compared to the consensus estimate of $103.80 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.McKesson’s revenue was up 10.2% on a year-over-year basis. During the same period last year, the company earned $7.07 earnings per share. Sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 1st will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s payout ratio is currently 10.21%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.